We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.14B
AUM Growth
+$467M
(+10%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
5.31%
Top 10 Holdings %
Top 10 Hldgs %
11.46%
Holding
1,074
New
159
Increased
412
Reduced
333
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$28.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.5M |
| 3 |
Toro Company
TTC
|
+$22.4M |
| 4 |
PepsiCo
PEP
|
+$20.4M |
| 5 |
Lockheed Martin
LMT
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$26.1M |
| 2 |
Wells Fargo
WFC
|
+$19.4M |
| 3 |
Centene
CNC
|
+$17.3M |
| 4 |
Eli Lilly
LLY
|
+$15.8M |
| 5 |
Kroger
KR
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 18.08% |
| 3 | Industrials | 12.96% |
| 4 | Healthcare | 11.05% |
| 5 | Consumer Discretionary | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECD
51
DELISTED
Tech Data Corp
TECD
| $23.8M | 0.46% |
268,154
+53,653
| +25% | +$5.29M |
|
52
Valero Energy
VLO
$90.6B
| $23.7M | 0.46% |
307,846
+12,166
| +4% | +$838K |
|
53
Cadence Design Systems
CDNS
$91.1B
| $23.5M | 0.46% |
596,463
+424,598
| +247% | +$15.6M |
|
|
AGN
54
DELISTED
Allergan plc
AGN
| $23.4M | 0.45% |
+114,141
| New | +$26.5M |
|
55
Textron
TXT
$16.2B
| $23.1M | 0.45% |
428,968
+4,513
| +1% | +$224K |
|
56
Emcor
EME
$34.2B
| $23M | 0.45% |
331,247
+37,905
| +13% | +$2.51M |
|
57
Capital One
COF
$123B
| $22.7M | 0.44% |
267,647
+22,827
| +9% | +$1.88M |
|
58
Cable One
CABO
$211M
| $22.3M | 0.43% |
30,940
+464
| +2% | +$343K |
|
|
AAN.A
59
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $21.8M | 0.42% |
499,577
+30,300
| +6% | +$1.32M |
|
60
Baxter International
BAX
$11.2B
| $21.6M | 0.42% |
343,825
-15,575
| -4% | -$962K |
|
61
Rockwell Automation
ROK
$51.3B
| $21.5M | 0.42% |
120,790
+173
| +0.1% | +$28.8K |
|
62
Northern Trust
NTRS
$21.9B
| $21.5M | 0.42% |
233,637
+42,165
| +22% | +$3.81M |
|
63
Madison Square Garden
MSGS
$9.49B
| $21.5M | 0.42% |
140,510
+18,739
| +15% | +$2.83M |
|
64
NOV
NOV
$7.22B
| $21.3M | 0.41% |
597,050
+17,926
| +3% | +$586K |
|
|
SNV
65
DELISTED
Synovus
SNV
| $21.3M | 0.41% |
462,410
+34,099
| +8% | +$1.48M |
|
|
ETFC
66
DELISTED
E*Trade Financial Corporation
ETFC
| $21.3M | 0.41% |
488,391
+4,170
| +0.9% | +$169K |
|
67
Gartner
IT
$8.95B
| $21.3M | 0.41% |
170,943
+80,352
| +89% | +$9.93M |
|
68
Archer Daniels Midland
ADM
$41.6B
| $21.2M | 0.41% |
499,411
+7,307
| +1% | +$308K |
|
69
Deere & Co
DE
$165B
| $21M | 0.41% |
167,064
+77,296
| +86% | +$9.53M |
|
|
70
Toro Company
TTC
$8.72B
| $21M | 0.41% |
337,758
+333,898
| +8,650% | +$22.4M |
|
71
Walt Disney
DIS
$161B
| $20.8M | 0.4% |
211,241
+20,141
| +11% | +$2.07M |
|
72
Edwards Lifesciences
EW
$48.3B
| $20.8M | 0.4% |
570,057
-29,907
| -5% | -$1.14M |
|
73
JPMorgan Chase
JPM
$930B
| $19.8M | 0.39% |
207,719
+18,399
| +10% | +$1.7M |
|
74
Reinsurance Group of America
RGA
$15.3B
| $19.8M | 0.38% |
141,862
+15,165
| +12% | +$2.05M |
|
75
Viavi Solutions
VIAV
$10.3B
| $19.8M | 0.38% |
2,088,883
+147,627
| +8% | +$1.54M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2017 Portfolio in Review
As of Q3 2017, Jacobs Levy Equity Management held 1,074 positions worth $5.14B, up 10% from $4.68B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management deployed $273M of net new capital in Q3 2017, opening 159 new positions and adding to 412 existing holdings. Its largest new stake was Allergan plc: 114,141 shares worth $23.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Intuit, an estimated $26.1M trimmed.
- Jacobs Levy Equity Management's largest Q3 2017 buy was Allergan plc: 114,141 shares worth $23.4M.
- Jacobs Levy Equity Management added most to Philip Morris in Q3 2017, an estimated $28.6M increase.
- Jacobs Levy Equity Management's biggest Q3 2017 reduction was Intuit, cutting an estimated $26.1M.
- Jacobs Levy Equity Management fully exited BWX Technologies in Q3 2017, selling an estimated $13.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $5.14B portfolio in Q3 2017.
- Jacobs Levy Equity Management opened 159 new positions and closed 136 in Q3 2017.
- Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $5.14B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2017, filed 14 Nov 2017.